eCOA

eCOA (electronic Clinical Outcome Assessments) by YPrime is a solution designed to streamline and enhance the clinical trial experience. According to the vendor, it aims to minimize the burdens and barriers of participating in clinical trials, potentially delivering cleaner data, improving efficiency, and increasing patient compliance. This product is intended for companies of all sizes involved in clinical trials and research studies, including pharmaceutical companies, contract research organizations (CROs), academic research institutions, biotechnology companies, and medical device manufacturers.

Key Features

eCOA Modalities: According to the vendor, eCOA offers multiple modalities that provide user choice and flexibility, potentially boosting patient compliance. The app-based architecture allows for a single build for all modalities, potentially improving accuracy and creating efficiencies.

eCOA Web Backup: To ensure continuous data collection, the vendor offers web-based backup solutions in case of device malfunction or patient travel restrictions. According to the vendor, this feature enables remote completion of site-based electronic patient-reported outcome (ePRO) and clinician-reported outcome (ClinRO) assessments, potentially minimizing missing data.

eCOA Science & Data Monitoring: The vendor claims to provide strategic counsel and implementation support to stay at the forefront of eCOA science. According to the vendor, their data monitoring services act as an early warning system for compliance or safety risks. They also offer data analytics for quick insights and to ensure data quality throughout the trial.

eCOA Device Strategy: The vendor offers purpose-built eCOA devices to collect high-quality data throughout the research. According to the vendor, these devices come with advanced security protocols, performance, longevity, and global coverage, allowing for global shipment and connectivity in long-term studies.

IRT Solutions to Help You Decipher the Complex: The vendor's IRT platform aims to simplify patient randomization and clinical supply management processes. According to the vendor, it integrates with other data systems, accommodating studies of various complexities, from simple early phase studies to late-stage trials with complex protocol requirements.

Early Phase Studies: According to the vendor, their fully featured yet simplified IRT platform enables rapid implementation and cost-effective management of early phase studies. It allows easy configuration of randomization and supply parameters to ensure data integrity and minimize risks to timelines.

Patient Innovation: The vendor claims that eCOA provides actionable insights into patient needs and priorities. It enables remote collection of patient-reported outcome (PRO) data and facilitates remote consent, potentially reducing the need for in-person visits. According to the vendor, focused questions aim to reduce the burden on patients by asking relevant and concise questions. The platform supports various data collection methods, including handheld devices, bring-your-own-device (BYOD), and web-based options, providing backup options for uninterrupted data collection.

DCT Solutions: According to the vendor, eCOA offers patient engagement solutions to improve compliance and retention rates in decentralized clinical trials (DCTs). They support direct-to-patient clinical supply strategies and provide round-the-clock global technical support for uninterrupted trial operation.

Data Science: The vendor claims to leverage scientific expertise to focus questions, optimize technology, and make sound business decisions regarding clinical supplies management. According to the vendor, eCOA enables tracking and accountability throughout the clinical supplies lifecycle, ensuring accurate reconciliation and minimizing potential discrepancies.